Vanderbilt Therapeutics Clinical Research Site

About our Clinical Research Site

Vanderbilt Therapeutics Clinical Research Site (VTCRS) has contributed to HIV Clinical Research for over 20 years. VTCRS is one of 29 AIDS Clinical Trials Group (ACTG) sites in the United States.

Our mission is to improve the health of people with HIV by:

- Discovering more about the virus and the immune system

- Testing new and improved treatments for HIV

- Finding treatments for other health problems that are associated with HIV

- Trying to find a CURE for HIV


In addition to conducting ACTG clinical trials, we are part of the Tennessee Center for AIDS Research (CFAR) and work on multiple studies led by local scientists, healthcare professionals, and HIV experts.


Dr. David Haas serves as our Medical Director and Principal Investigator.

Beverly Woodward, MSN, RN serves as our Site Coordinator and Research Manager.


David Haas

David Haas and Beverly Woodward pose in a treatment room used for COVID-19 research


We are located with the Vanderbilt Comprehensive Care Clinic.

Links and Affiliations